摘要：
2025年12月23日和27日, 北京大学药学院药剂学系齐宪荣教授团队连续在Nature Communications (IF = 15.7)发表了题为“Leveraging engineered mitochondria through intercellular communication network for accelerated transport and delivery”和Acta Biomaterialia (IF = 9.6)发表了题为“Mitochondrial transfer through tunneling nanotubes inspires an innovative strategy for intercellular drug delivery”的系列研究论文, 构建“线粒体自主驱动”系统, 开发了一种创新的药物递送策略, 借助隧道纳米管实现线粒体介导的深层药物递送与肿瘤治疗。
Supporting:
北京大学药学院药剂学系. 让药物搭载线粒体驶上“高速路”—齐宪荣团队创新性地提出利用线粒体作为药物载体, 通过隧道纳米管实现细胞间的药物运输[J]. 中国药学(英文版), 2026, 35(2): 206-208.
Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Xianrong Qi innovatively proposed the use of mitochondria as drug carriers and the realization of #br#
intercellular drug delivery through tunneling nanotubes#br#[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(2): 206-208.
>
>